Leaflet: information for the user
Risperidone Flas Krka 0.5 mg buccal tablets EFG
Read this leaflet carefully before you start taking this medicine, as it contains important information for you.
1. What Risperidone Flas Krka is and what it is used for
2. What you need to know before starting to take Risperidone Flas Krka
3. How to take Risperidone Flas Krka
4. Possible side effects
5. Storage of Risperidone Flas Krka
6. Contents of the pack and additional information
Risperidona belongs to a group of medicines called “antipsychotics”.
Risperidona Flas Krka is used to treat the following:
Risperidona may help reduce the symptoms of your illness and prevent them from returning.
Do not take Risperidona Flas Krka
If you are unsure whether the information applies to you, consult your doctor or pharmacist before using Risperidona Flas Krka.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Risperidona Flas Krka if:
If you are unsure whether the information above applies to you, consult your doctor or pharmacist before using Risperidona Flas Krka.
Because, in rare cases, a dangerous drop in the number of certain types of white blood cells necessary to fight infections in the blood has been observed in patients taking risperidone, your doctor may check your white blood cell counts in the blood.
Risperidona Flas Krka may cause you to gain weight. A significant weight gain may affect your health unfavourably. Your doctor will regularly monitor your weight.
Because diabetes mellitus or worsening of pre-existing diabetes mellitus has been seen in patients taking Risperidona Flas Krka, your doctor should check for signs of elevated blood sugar. In patients with pre-existing diabetes mellitus, blood sugar should be monitored.
Risperidona Flas Krka frequently increases levels of a hormone called prolactin. This may cause adverse effects such as menstrual disorders or fertility problems in women or breast swelling in men (see Possible adverse effects). If these adverse effects occur, it is recommended that prolactin levels in the blood be evaluated.
During eye surgery for cataract, the pupil (the black circle in the centre of your eye) may not enlarge enough. In addition, the iris (the coloured part of your eye) may become flexible during the procedure and may cause eye damage. If you are planning eye surgery, make sure to tell your ophthalmologist that you are taking this medicine.
Patients with advanced age and dementia
In patients with advanced age and dementia, there is an increased risk of having a stroke. Do not take risperidone if you have dementia caused by a stroke.
During treatment with risperidone, you should see your doctor regularly.
If you or your caregiver notice a sudden change in your mental state or the sudden appearance of weakness or numbness in the face, arms or legs, especially on one side, or speak confusedly, even for a short time, seek medical treatment immediately. This may be a sign of a stroke.
Children and adolescents
Other causes of aggressive behaviour should be ruled out before starting treatment for conduct disorders.
If during treatment with risperidone you experience fatigue, changing the administration times may improve your difficulties with attention.
Before starting treatment, your weight or that of your child should be measured, and it should be monitored regularly during treatment.
A small, inconclusive study has reported an increase in the height of children who took risperidone, but it is unknown whether this is a side effect of the drug or due to another reason.
Other medicines and Risperidona Flas Krka
Inform your doctor or pharmacist if you are taking, have recently taken or may need to take any other medicine.
It is especially important to talk to your doctor or pharmacist if you are taking any of the following products:
The following medicines may reduce the effect of risperidone:
If you start or stop taking these medicines, you may need a different dose of risperidone.
The following medicines may increase the effect of risperidone:
If you start or stop taking these medicines, you may need a different dose of risperidone.
If you are unsure whether the information above applies to you, consult your doctor or pharmacist before using Risperidona Flas Krka.
Taking Risperidona Flas Krka with food, drinks and alcohol
You can take this medicine with or without food. You should avoid consuming alcohol while taking Risperidona Flas Krka.
Pregnancy, breastfeeding and fertility
Driving and operating machinery
During treatment with Risperidona Krka, you may experience dizziness, fatigue and vision problems. Do not drive or operate machinery without consulting your doctor first.
Risperidona Flas Krka contains aspartame (E951)
This medicine contains 0.40 mg of aspartame in each 0.5 mg buccal dispersible tablets. Aspartame contains a source of phenylalanine that may be harmful in the case of phenylketonuria (PKU), a rare genetic disease in which phenylalanine accumulates because the body is unable to eliminate it correctly.
Follow exactly the administration instructions of this medication as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Please note that not all doses of these medications are commercially available or that not all recommended doses can be administered with these medications. Other pharmaceutical forms/doses may be available for prescription.
The recommended dose is as follows:
For the treatment of schizophrenia
Adults
Older adults
For the treatment of mania
Adults
Older adults
For the treatment of long-term aggression in people with Alzheimer's dementia
Adults (including older adults)
Use in children and adolescents
For the treatment of behavioral disorders
The dose will depend on your child's weight:
If they weigh less than 50 kg
If they weigh 50 kg or more
The duration of treatment in patients with behavioral disorders should not exceed 6 weeks.
Children under 5 years old should not receive risperidone treatment for behavioral disorders.
Patients with liver or kidney problems
Unless the disease being treated is taken into account, all initial doses and subsequent doses of risperidone should be reduced by half. Dose increases should be made more slowly in these patients.
Risperidone should be used with caution in this group of patients.
Administration form
Oral administration.
Risperidone Flas Krka buccodispersible tablets are fragile. Do not press them through the foil in the blister pack as this will damage the tablet. Remove a tablet from the pack as follows:
1. Hold the blister pack by the edges and separate one blister from the rest of the strip along the perforations.
2. Lift the corner of the foil and remove it completely.
3. Empty the tablet into your hand.
4. Place the tablet on your tongue as soon as you remove it from the pack.
In a few seconds, it will start to dissolve in your mouth and you can swallow it with or without water. Your mouth should be empty before placing the tablet on your tongue.
You can also place the tablet in a glass or cup filled with water and drink it immediately.
If you take more Risperidone Flas Krka than you should
If you forget to take Risperidone Flas Krka
If you interrupt treatment with Risperidone Flas Krka
Do not stop taking the medication unless your doctor tells you to. Symptoms may reappear. If your doctor decides to stop treatment, your dose may be gradually reduced over a few days.
If you have any other questions about using this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Inform your doctor immediately if you experience any of the following rare side effects (may affect up to 1 in 1,000 people):
The following side effects may occur:
Very common (may affect more than 1 in 10 people):
Common (may affect up to 1 in 10 people):
Rare (may affect up to 1 in 100 people):
Rare (may affect up to 1 in 1,000 people):
Very rare (may affect up to 1 in 10,000 people):
Frequency unknown: the frequency cannot be estimated from available data
The following side effects have appeared with the use of another medicine called paliperidone, which is very similar to risperidone, so it is also expected to appear with Risperidona Krka: Rapid heartbeat when standing up.
Other side effects in children and adolescents
In general, it is expected that side effects in children will be similar to those that appeared in adults.
The following side effects were reported more frequently in children and adolescents (5 to 17 years) than in adults: Feeling drowsy, or less attentive, fatigue (tiredness), headache, increased appetite, vomiting, common cold symptoms, nasal congestion, abdominal pain, dizziness, cough, fever, tremor (shaking), diarrhea, and urinary incontinence.
Reporting side effects
If you experienceany type of side effect, consult your doctor or pharmacist, even if it is apossibleside effect that does not appear in this leaflet.You can also report them directly through theSpanish System for Pharmacovigilance of Medicines for Human Useor:www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging. The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Medications should not be disposed of through drains or in the trash. Dispose of the packaging and medications you no longer need at the SIGRE point of your pharmacy. Ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.
Risperidone Flas Krka Composition
See section 2 “Risperidone Flas Krka contains aspartame (E951)”.
Appearance of the product and contents of the package
The buccal dispersible tablets are pink speckled, round, slightly convex tablets.
Package sizes: 20, 28, 30, 50, 56, 60, 98 or 100 tablets in blisters.
Only some package sizes may be commercially available.
Marketing authorization holder and manufacturer
Marketing authorization holder
KRKA, d.d., Novo mesto
Smarjeska cesta 6
8501 Slovenia
Manufacturer
KRKA, d.d., Novo mesto
Smarjeska cesta 6
8501 Slovenia
For more information about this medication, please contact the Local Representative of the Marketing Authorization Holder:
KRKA Farmacéutica, S.L., C/ Anabel Segura 10, Pta. Baja, Oficina 1, 28108 Alcobendas, Madrid, Spain
This medication is registered in the member states of the European Economic Area and in the United Kingdom (Northern Ireland) with the following names:
GermanyRisperidon TAD 0.5 mg Schmelztabletten
DenmarkRisperidon Krka
SpainRisperidone Flas Krka 0.5 mg Buccal Dispersible Tablets EFG
EstoniaTorendo Q-Tab 0.5 mg
FinlandRisperidon Krka 0.5 mg Orodispersible Tablets
HungaryTorendo Q-Tab 0.5 mg
LithuaniaTorendo Q-Tab 0.5 mg, orodispersible tablets
NorwayRisperidon Krka 0.5 mg Orodispersible Tablets
PolandTorendo Q-Tab 0.5 mg
PortugalRisperidon Krka
United KingdomRisperidone 0.5 mg Orodispersible Tablets
Czech RepublicRorendo Oro Tab 0.5 mg, orodispersible tablets
Slovak RepublicTorendo Q-Tab 0.5 mg
SwedenRisperidon Krka 0.5 mg ODT tablet
Last review date of this leaflet: March 2023
For more detailed information about this medication, please visit the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.